Encompass Health Corp
EHCUS売上高
$5.9B
百万USD
営業利益
-
百万USD
純利益
$566M
百万USD
ROE
23.2%
最新FY
EPS
$5.54
USD / 株
配当
$0.72
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $1.2B | $107M | $1.07 |
| FY2021 | Q2 | $1.3B | $113M | $1.13 |
| FY2021 | Q3 | $1.3B | $100M | $1.00 |
| FY2021 | FY | $5.1B | $412M | $4.11 |
| FY2022 | Q1 | $1.3B | $88M | $0.87 |
| FY2022 | Q2 | $1.3B | $49M | $0.49 |
| FY2022 | Q3 | $1.1B | $45M | $0.45 |
| FY2022 | FY | $4.3B | $271M | $2.70 |
| FY2023 | Q1 | $1.2B | $88M | $0.87 |
| FY2023 | Q2 | $1.2B | $91M | $0.90 |
| FY2023 | Q3 | $1.2B | $85M | $0.84 |
| FY2023 | FY | $4.8B | $352M | $3.47 |
| FY2024 | Q1 | $1.3B | $113M | $1.10 |
| FY2024 | Q2 | $1.3B | $114M | $1.12 |
| FY2024 | Q3 | $1.4B | $108M | $1.06 |
| FY2024 | FY | $5.4B | $456M | $4.46 |
| FY2025 | Q1 | $1.5B | $152M | $1.48 |
| FY2025 | Q2 | $1.5B | $142M | $1.39 |
| FY2025 | Q3 | $1.5B | $127M | $1.24 |
| FY2025 | FY | $5.9B | $566M | $5.54 |
| FY2026 | Q1 | $1.6B | $195M | $1.93 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $4.3B | $4.6B | $4.6B | $5.1B | $4.3B | $4.8B | $5.4B | $5.9B |
| 営業利益 | $588M | $578M | $555M | $612M | $564M | - | $540M | - | - | - |
| 純利益 | $248M | $256M | $292M | $359M | $284M | $412M | $271M | $352M | $456M | $566M |
| 総資産 | $4.7B | $4.9B | $5.2B | $6.1B | $6.4B | $6.9B | $5.6B | $6.1B | $6.5B | $7.1B |
| 純資産 | $929M | $1.4B | $1.6B | $1.7B | $2.0B | $2.4B | $1.8B | $2.3B | $2.8B | $3.2B |
| 自己資本 | $736M | $1.2B | $1.3B | $1.4B | $1.6B | $1.9B | $1.3B | $1.6B | $2.1B | $2.4B |
| 営業CF | $606M | $657M | $762M | $635M | $705M | $716M | $706M | - | - | - |
| EPS | $2.59 | $2.69 | $2.93 | $3.61 | $2.85 | $4.11 | $2.70 | $3.47 | $4.46 | $5.54 |
| BPS | $8.26 | $12.04 | $12.93 | $13.74 | $16.00 | $19.22 | $13.14 | $16.45 | $20.52 | $24.53 |
| ROE | 33.6% | 21.7% | 22.9% | 26.5% | 17.9% | 21.6% | 20.7% | 21.4% | 22.0% | 23.2% |